Advisory Board and Editors Microbiology
Luis E Eguiarte
Professor of the Evolutionary Ecology Department at the Institute of Ecology of the National Autonomous University of Mexico (UNAM).
Jonathan A Eisen
Full Professor, University of California, Davis (Depts. of Medical Microbiology and Immunology and Evolution and Ecology) and Adjunct Scientist DOE Joint Genome Institute.
Obsessed with microbes, the Redsox, open science, and STEM diversity.
Mohamed A. El-Esawi
Dr. Mohamed A. El-Esawi is Professor at Faculty of Science, Tanta University, Egypt. Dr. El-Esawi received his BSc and MSc from Tanta University, and his Ph.D. degree from Dublin Institute of Technology, Technological University Dublin, Ireland. After obtaining his Ph.D., Dr. El-Esawi joined the University of Warwick in the United Kingdom, University of Sorbonne in France, University of Leuven (KU Leuven) in Belgium and University of Cambridge in the United Kingdom as a visiting research fellow. His research focuses on genetics, molecular biology, environmental health and safety, environmental stress, biotechnology, molecular physiology, developmental biology, and bioinformatics. He has authored more than 150 international peer-reviewed articles, book chapters, books, and patents, and has participated in more than 70 conferences and workshops worldwide. Dr. El-Esawi has received several grants and international awards and recognition, including the Plants 2021 Young Investigator Award (MDPI, Switzerland). He has been ranked among the world's top 2% Scientists by Stanford University in USA, and is currently involved in several research projects.
Barbara Ensoli
Director of the National AIDS Center, Istituto Superiore di Sanità, Rome, Italy. Co-Vice President and Member of the Presidential Committee of the AIDS National Commission, Ministry of Health. Member of the European Molecular Biology Organisation (EMBO).
A. Murat Eren
I am a computer scientist and a microbial ecologist. I develop algorithms and software platforms to make sense of the ecology of microbes through marker genes, metagenomes, and metatranscriptomes.
Ana E Escalante
Dr. Ana E. Escalante, a PhD in microbial ecology and evolution, has extensively studied microbial diversity and evolution in natural and engineered ecosystems. Since 2011, she has been at the National Laboratory of Sustainability Sciences (LANCIS), focusing on sustainability, particularly its implications for public policy and ecosystem management. With >50 scientific articles, numerous supervised theses, and teaching roles in multiple graduate programs. Since 2020 she serves as director of the Institute of Ecology at the National Autonomous University of Mexico (UNAM).
Alda Maria Ferreira
I have a master's degree in microbiology and PhD in Cellular and Molecular Biology. I am an Associate Professor of Immunology at the Federal University of Mato Grosso do Sul, Brazil. I have already supervised six master's and one doctoral students in the areas of biochemistry and infectious diseases.
My main area of interest is cellular and molecular biology of pathogens, infectious diseases and biological assays. So far I have published several papers involving studies in these areas.
I am the leader of a research group certified by the CNpQ (National Council for Scientific and Technological Development) on biological assays with >Trypanosoma cruzi<, which is the etiologic agent of Chagas disease.
B. Brett Finlay
The Peter Wall Distinguished Professor of the University of British Colombia. Recipient of several awards including the E.W.R. Steacie Prize, the CSM Fisher Scientific Award, an MRC Scientist, five Howard Hughes International Research Scholar Awards, a CIHR Distinguished Investigator, BC Biotech Innovation Award, the Michael Smith Health Research Prize, the IDSA Squibb award, the Jacob Biely Prize. Cofounder of Inimex Pharmaceuticals, Inc., and Director of the SARS Accelerated Vaccine Initiative
Carla Fiorentini
CARLA FIORENTINI is presently Director of Preclinical Research at the Association for Research of Integrative Oncology Therapies (ARTOI). She was Director of “Natural Substances, Traditional Medicine” Section at the Dept. of Therapeutic Research and Medicines Evaluation, and Coordinator of a Research Group at the Italian Center for Global Health, Istituto Superiore di Sanità (ISS), Roma. Academic Degree in Biology and Specialty in Microbiology, University of Roma. Post-doctoral training at Karolinska Institutet, Stockholm, Sweden. Her current research is focused on unravelling the role of bacterial protein toxins in cancer and on the use the bacterial toxin CNF1 as a potential novel therapeutic for central nervous system disorders. She is co-inventor in five different patents on CNF1 activity on the central nervous system. As co-author of numerous book chapters and articles in leading journals, she is renowned in the field of bacterial protein toxins.
Daniel Fischer
I studied Statistics and Computer Sciences at the Technical University of Dortmund, Germany. During that time, my interest was particularly in mathematical statistics with a focus on high-dimensional extensions of the univariate median. After graduating, I moved to Tampere, Finland and completed my PhD in at the University of Tampere in Biostatistics with minor Bioinformatics.
While still being enrolled as PhD student at the University I started to work as a researcher in Bioinformatics at the MTT, Jokioinen, Finland. Since 2015 I am working at the Natural Resources Institute Finland (Luke) where I finalized my PhD.
My published articles in peer-reviewed journals cover a wide range of applications as well as statistical theory. My areas of expertise are target gene detection, biomarker identification and novel gene detection with a special focus on long non-coding RNAs. Further, I have experiences in the development of statistical methods for DE testing as well as deriving novel non-parametrical tests for (e)QTL analyses. I published and maintain currently six R-packages, i.e. for (e)QTL testing, cross-species ortholog detection and dimension reduction methods.
Suzanne M.J. Fleiszig
Professor, University of California, Berkeley. Programs in Optometry, Vision Science, Infectious Disease and Immunity, and Microbiology. Vice President, Tear Film and Ocular Surface Society. Former President, International Society for Contact Lens Research. Councillor, American Society for Microbiology. Recipient of the 2005 Glenn A. Fry Award and the 2010 Korb Award. Editorial Boards: PLoS ONE, Infection & Immunity, and Investigative Ophthalmology & Vision Science.
Mario Alberto Flores-Valdez
Dr. Mario Alberto Flores-Valdez is a Professor in the Medical and Pharmaceutical Biotechnology Unit, CIATEJ, A.C., Guadalajara, Jalisco, Mexico (2007-present). He is a member of the National System of Researchers (SNI), and a member of the Mexican Academy of Sciences. He was a Stanford University Medical Center postdoctoral fellow (2004-2007), where he received a Dean's Fellowship Award (2006) to conduct research on Tuberculosis. He worked in UNAM as Research Assistant for Prof. Jaime Mora (2004) and Prof. Emundo Calva (2003). He has received a Ph.D. in Biochemistry from UNAM (1999-2003), a M.Sc. in Molecular Biology and Genetic Engineering from UANL (1996-1999) and a B.Sc. from Universidad de Sonora (1991-1996) in Chemistry and Biology. He received fellowships from CONACYT for M.Sc. and Ph.D. studies and in M.Sc. and B.Sc. has received Diplomas as Best Student. He has expertise in Tuberculosis, particularly in developing recombinant BCG strains. He has been PI for 7 grants from 2008 to date, focused in studies about tuberculosis vaccine development and basic aspects of mycobacterial physiology.